Skip to main content

News

We are focused on helping people live healthier, happier and longer by providing reliable healthcare solutions through innovation, technological advancement and commitment to quality.

Press Release

07 November 2005
CyGenics takes 51% equity in an Australian cord blood banking business
06 October 2005
CyGenics secures exclusive licence on enhanced T cell production technologies from the Brigham and Women’s Hospital Exclusive worldwide licence from Harvard Medical School teaching affiliate
30 September 2005
Annual Report, 2005
13 September 2005
Cord Blood Misconceptions Dispelled
06 September 2005
CordLife is Southeast Asia’s First AABB Accredited Cord Blood Bank
31 August 2005
CyGenics reports a 40 per cent increase in revenue
01 August 2005
CyGenics Quarterly Newsletter August 2005
08 July 2005
Change Of Director's Interest Notice
04 July 2005
Manager of Company Announcements Australian Stock Exchange
20 June 2005
CyGenics forms new US subsidiary CytoVations to acquire and develop cell technology
16 May 2005
CyGenics strengthens Melbourne operations
29 April 2005
Manager of Company Announcements Australian Stock Exchange